VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.590
-0.005 (-0.82%)
At close: Mar 9, 2026, 4:00 PM EDT
0.585
-0.005 (-0.88%)
After-hours: Mar 9, 2026, 5:28 PM EDT
VYNE Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 24.03 | 19.93 | 30.62 | 30.91 | 42.25 | Upgrade
|
| Short-Term Investments | 4.98 | 41.59 | 62.63 | - | - | Upgrade
|
| Cash & Short-Term Investments | 29.01 | 61.52 | 93.25 | 30.91 | 42.25 | Upgrade
|
| Cash Growth | -52.84% | -34.03% | 201.71% | -26.85% | -27.89% | Upgrade
|
| Accounts Receivable | - | - | - | - | 7.58 | Upgrade
|
| Other Receivables | - | - | - | 5 | - | Upgrade
|
| Receivables | - | - | - | 5 | 7.58 | Upgrade
|
| Prepaid Expenses | 1 | 2.92 | 2.66 | 2.3 | 4.57 | Upgrade
|
| Restricted Cash | - | - | 0.05 | 0.07 | 0.61 | Upgrade
|
| Other Current Assets | - | - | - | - | 8.18 | Upgrade
|
| Total Current Assets | 30.01 | 64.44 | 95.96 | 38.28 | 63.19 | Upgrade
|
| Property, Plant & Equipment | 0.09 | 0.21 | 0.21 | - | 0.35 | Upgrade
|
| Other Long-Term Assets | 0.06 | 2.26 | 1.52 | 2.48 | 3.51 | Upgrade
|
| Total Assets | 30.16 | 66.91 | 97.69 | 40.76 | 67.05 | Upgrade
|
| Accounts Payable | 1.04 | 2.71 | 1.66 | 2.39 | 6.51 | Upgrade
|
| Accrued Expenses | 1.35 | 8.59 | 3.51 | 4.26 | 6.06 | Upgrade
|
| Current Portion of Leases | - | 0.1 | 0.12 | - | 0.35 | Upgrade
|
| Other Current Liabilities | - | 3.42 | 2.25 | 2.7 | 5.49 | Upgrade
|
| Total Current Liabilities | 2.4 | 14.82 | 7.54 | 9.35 | 18.41 | Upgrade
|
| Long-Term Leases | - | - | 0.1 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 1.31 | - | - | Upgrade
|
| Total Liabilities | 2.4 | 14.82 | 8.95 | 9.35 | 18.41 | Upgrade
|
| Common Stock | 0 | 0 | 0 | - | 0.01 | Upgrade
|
| Additional Paid-In Capital | 785.41 | 783.24 | 780.04 | 693.94 | 688.16 | Upgrade
|
| Retained Earnings | -757.65 | -731.17 | -691.34 | -662.74 | -639.53 | Upgrade
|
| Comprehensive Income & Other | 0 | 0.02 | 0.03 | - | - | Upgrade
|
| Total Common Equity | 27.77 | 52.09 | 88.74 | 31.2 | 48.64 | Upgrade
|
| Shareholders' Equity | 27.77 | 52.09 | 88.74 | 31.41 | 48.64 | Upgrade
|
| Total Liabilities & Equity | 30.16 | 66.91 | 97.69 | 40.76 | 67.05 | Upgrade
|
| Total Debt | - | 0.1 | 0.21 | - | 0.35 | Upgrade
|
| Net Cash (Debt) | 29.01 | 61.42 | 93.04 | 30.91 | 41.9 | Upgrade
|
| Net Cash Growth | -52.77% | -33.99% | 201.02% | -26.24% | 76.01% | Upgrade
|
| Net Cash Per Share | 0.68 | 1.44 | 9.06 | 9.70 | 14.66 | Upgrade
|
| Filing Date Shares Outstanding | 33.32 | 15.21 | 14.1 | 3.26 | 3.12 | Upgrade
|
| Total Common Shares Outstanding | 33.32 | 14.83 | 14.1 | 3.23 | 2.98 | Upgrade
|
| Working Capital | 27.62 | 49.62 | 88.43 | 28.93 | 44.78 | Upgrade
|
| Book Value Per Share | 0.83 | 3.51 | 6.29 | 9.66 | 16.34 | Upgrade
|
| Tangible Book Value | 27.77 | 52.09 | 88.74 | 31.2 | 48.64 | Upgrade
|
| Tangible Book Value Per Share | 0.83 | 3.51 | 6.29 | 9.66 | 16.34 | Upgrade
|
| Machinery | 0.12 | 0.12 | - | - | 0.85 | Upgrade
|
| Leasehold Improvements | - | - | - | - | 0.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.